v1
A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients.
Identifier:nobleid.org/w1/20260515/D36CE233
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/D36CE233)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims